1. Home
  2. Vol 56, No 2 (2024)
  3. Rachman

Genotypic Analysis of Transmitted and Acquired HIV Drug Resistance in People Living with HIV/AIDS in Surabaya, Indonesia, from 2018 to 2019

Brian Eka Rachman, Ni Luh Ayu Megasari, Siti Qamariyah Khairunisa, Tomohiro Kotaki, M Vitanata Arfijanto, Usman Hadi, Nasronudin Nasronudin, Masanori Kameoka

Abstract


Background: Despite the availability of various effective antiretroviral (ARV) drugs, human immunodeficiency virus (HIV) infection has come with HIV drug resistance (HIVDR), which compromises its effectiveness in reducing HIV-related morbidity, mortality, and transmission. The emergence of transmitted (TDR) and acquired HIVDR (ADR) among antiretroviral therapy (ART)-naïve and experienced individuals have been reported in several Indonesian regions. Therefore, continuous HIVDR surveillance is needed in Indonesia, especially in Surabaya, which is identified as having the highest prevalence of HIV infection in East Java; thus, this study aimed to identify the emergence of TDR and ADR among people living with HIV/acquired immune deficiency syndrome (AIDS) (PLWHA). Methods: Fifty-eight PLWHA infected with HIV type 1 (HIV-1), comprising 21 and 37 ART-naïve and experienced individuals were enrolled in this study, respectively. Blood samples collected from study participants were subjected to genotypic analysis, mainly towards the pol gene encoding protease (PR gene) and reverse transcriptase (RT gene) of HIV-1. Results: Seventeen PR and 21 RT genes were successfully amplified and sequenced from 29 samples. HIV-1 subtyping revealed CRF01_AE as the most dominant subtype (24/29; 82.76%), followed by subtype B (3/29; 10.34%). Uncommon subtypes, including subtype D and a recombinant containing subtypes B and G genomic fragments, were also identified. TDR for PR inhibitors was not detected; however, TDR and ADR for RT inhibitors were identified in 11.11% and 41.67% of samples, respectively. Two amino acid insertions at position 69 of the RT gene (69ins), a previously never-reported mutation in Indonesia, were identified in this study. Conclusion: Both TDR and ADR have emerged among PLWHA residing in Surabaya, East Java, Indonesia. Uncommon drug-resistance mutations and subtypes were identified in this study. These situations might hamper ART efficacy and treatment success. Continuous surveillance of HIVDR is necessary to monitor both TDR and ADR in Indonesia.


Keywords


HIV-1; Surabaya; antiretroviral therapy (ART); transmitted HIV drug resistance (TDR); acquired HIV drug resistance (ADR)

References


Joint United Nations Programme on HIV/AIDS (UNAIDS). Fact Sheet 2022. UNAIDS: Geneva; 2022.

Tyler R. Kemnic, Peter G. Gulick. HIV antiretroviral therapy. StatPearls Publishing: Treasure Island (FL); 2023.

Indonesian Ministry of Health. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/90/2019 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana HIV. 2019.

Megasari NLA, Wijaksana IKE. Factors affecting HIV viral load of antiretroviral therapyexperienced and naïve individuals residing in Bali, Indonesia. Mal J Med Health Sci 2023;19(Supp 3):111–5.

the AFRICOS Study Group, Bahemana E, Esber A, et al. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study. AIDS Res Ther 2020;17(1):66; doi: 10.1186/s12981-020-00323-x.

Pimentel GS, Ceccato M das GB, Costa J de O, et al. Qualidade de vida em indivíduos iniciando a terapia antirretroviral: um estudo de coorte. Rev saúde pública 2020;54:146; doi: 10.11606/s1518-8787.2020054001920.

World Health Organization. HIV drug resistance report 2021. World Health Organization: Geneva; 2021.

Pratama MohHR, Arfijanto MV, Lusida MLI. CD4 association with mortality in HIV patients with dyspnea in Dr Seotomo general academic Hospital Surabaya. CIMRJ 2023;4(1):20–22; doi: 10.20473/cimrj.v4i1.42609.

Khairunisa SQ, Megasari NLA, Ueda S, et al. 2018–2019 Update on the molecular epidemiology of HIV-1 in Indonesia. AIDS Research and Human Retroviruses 2020;36(11):957–963; doi: 10.1089/aid.2020.0151.

Khairunisa SQ, Megasari NLA, Indriati DW, et al. Identification of HIV-1 subtypes and drug resistance mutations among HIV-1-infected individuals residing in Pontianak, Indonesia. Germs 2020;10(3):174–83. doi: 10.18683/germs.2020.1203.

Khairunisa SQ, Megasari NLA, Rahayu RP, et al. Detection of human immunodeficiency virus type 1 transmitted drug resistance among treatment-Naive individuals residing in Jakarta, Indonesia. Infectious Disease Reports 2020;12(11):8740; doi: 10.4081/idr.2020.8740.

Khairunisa SQ, Megasari NLA, Ueda S, et al. Subtype distribution and drug resistance patterns among HIV-1 strains prevalent in Makassar, Indonesia. AIDS Research and Human Retroviruses 2023;39(3):124–29; doi: 10.1089/aid.2022.0139.

Megasari NLA, Oktafiani D, Ana EF, et al. Genotypic characterization of human immunodeficiency virus type 1 isolated from antiretroviral treatment-experienced individuals in Buleleng regency, Bali, Indonesia. AIDS Research and Human Retroviruses 2019;35(8):769–74; doi: 10.1089/aid.2019.0058.

Megasari NLA, Oktafiani D, Fitriana E, et al. The emergence of HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naive individuals in Buleleng, Bali, Indonesia. Acta Med Indones. 2019;51(3):197–204.

Widiyanti M, Fitriana E, Natalia EI, et al. Identification of antiretroviral mutation in protease and reverse trancriptase inhibitor in human immunodeficiency virus-1 of HIV/AIDS patients in Mimika regency, Papua. FMI 2017;53(1):56; doi: 10.20473/fmi.v53i1.5491.

Khairunisa SQ, Kotaki T, Witaningrum AM, et al. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients. AIDS Research and Human Retroviruses. 2015;31(2):255–9; doi: 10.1089/aid.2014.0221.

Kotaki T, Khairunisa SQ, Witaningrum AM, et al. HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naïve individuals in Surabaya, Indonesia. AIDS Res Ther 2015;12(1):5; doi: 10.1186/s12981-015-0046-y.

Indonesian Ministry of Health. Laporan situasi perkembangan HIV AIDS dan PIMS di Indonesia Januari-Desember 2019. Jakarta; 2019.

Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular biology and evolution 2016;33(7):1870–4; doi: 10.1093/molbev/msw054.

Wensing AM, Calvez V, Ceccherini-Silberstein F, et al. 2022 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2022;30(4):559–74.

Kotaki T, Khairunisa SQ, Sukartiningrum SD, et al. High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, Indonesia. PLoS One. 2013;8(12):e82645; doi: 10.1371/journal.pone.0082645.

Hemelaar J, Elangovan R, Yun J, et al. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey. The Lancet HIV 2020;7(11):e772–e781; doi: 10.1016/S2352-3018(20)30252-6.

Fernández-García A, Delgado E, Cuevas MT, et al. Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain. In: Tee KK,. ed. PLoS ONE. 2016;11(2):e0148549; doi: 10.1371/journal.pone.0148549.

Vázquez-Valls E, Escoto-Delgadillo M, López-Márquez FC, et al. Molecular epidemiology of HIV type 1 in Mexico: Emergence of BG and BF intersubtype recombinants. AIDS Research and Human Retroviruses. 2010;26(7):777–81; doi: 10.1089/aid.2009.0195.

Bennett DE, Myatt M, Bertagnolio S, et al. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008;13 Suppl 2:25–36.


Full Text: PDF

Refbacks

  • There are currently no refbacks.